Key pipeline advancements to propel myelodysplastic syndromes market to $2.4 bn by 2028: GlobalData
Despite the recent surge of development within the MDS space, KOLs argue that the level of unmet need remained dire.
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.